Gsk (GLAXF) Inventory Average (2009 - 2026)

Gsk's Inventory Average history runs 18 years deep, the most recent figure standing at $8.1 billion for Q1 2026.

• In Q1 2026, Inventory Average rose 9.08% year-over-year to $8.1 billion; the TTM figure through Mar 2026 stood at $8.1 billion (up 9.08% YoY), while the FY2025 annual figure was $7.5 billion, up 6.9% from the prior year.
• Inventory Average was $8.1 billion for Q1 2026 at Gsk, roughly flat from $8.1 billion in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $8.2 billion in Q3 2025 to a low of $3.6 billion in Q2 2022.
• Historically, Inventory Average has averaged $6.8 billion across 5 years, with a median of $7.0 billion in 2024.
• The sharpest annual moves came in 2022 and 2023: Inventory Average sank 58.69% in 2022, then soared 86.29% in 2023.
• A 5-year view of Inventory Average shows it stood at $5.8 billion in 2022, then grew by 19.42% to $6.9 billion in 2023, then climbed by 8.72% to $7.5 billion in 2024, then increased by 7.82% to $8.1 billion in 2025, then grew by 0.28% to $8.1 billion in 2026.
• The last three Inventory Average figures came in at $8.1 billion (Q1 2026), $8.1 billion (Q4 2025), and $8.2 billion (Q3 2025), per Business Quant data.